PAOLINO, SABRINA
 Distribuzione geografica
Continente #
EU - Europa 14.866
AS - Asia 1.109
SA - Sud America 219
NA - Nord America 208
AF - Africa 25
Totale 16.427
Nazione #
IT - Italia 14.831
SG - Singapore 403
CN - Cina 312
VN - Vietnam 289
US - Stati Uniti d'America 169
BR - Brasile 145
AR - Argentina 43
HK - Hong Kong 43
MX - Messico 31
ID - Indonesia 26
BD - Bangladesh 9
EC - Ecuador 8
CO - Colombia 6
PY - Paraguay 6
RU - Federazione Russa 6
SE - Svezia 6
ZA - Sudafrica 6
FI - Finlandia 5
CA - Canada 4
CL - Cile 4
GB - Regno Unito 4
IN - India 4
VE - Venezuela 4
AZ - Azerbaigian 3
ES - Italia 3
IQ - Iraq 3
KE - Kenya 3
MA - Marocco 3
NL - Olanda 3
TR - Turchia 3
EG - Egitto 2
GT - Guatemala 2
JP - Giappone 2
LT - Lituania 2
PK - Pakistan 2
PL - Polonia 2
SN - Senegal 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CV - Capo Verde 1
FR - Francia 1
GH - Ghana 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
ML - Mali 1
MR - Mauritania 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
SO - Somalia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UY - Uruguay 1
ZW - Zimbabwe 1
Totale 16.427
Città #
Genova 6.506
Genoa 6.037
Vado Ligure 1.188
Rapallo 1.038
Singapore 132
Ho Chi Minh City 98
Beijing 94
Hanoi 71
Ashburn 50
Bordighera 47
New York 44
Hong Kong 43
Mexico City 24
Haiphong 17
Los Angeles 12
Orem 10
Tianjin 10
Biên Hòa 9
Thái Nguyên 8
Hải Dương 7
São Paulo 7
Thái Bình 7
Da Nang 6
Rio de Janeiro 6
Chicago 5
Jakarta 5
Stockholm 5
Bắc Giang 4
Can Tho 4
Curitiba 4
Denver 4
Lappeenranta 4
Montreal 4
Ninh Bình 4
Quito 4
Brasília 3
Buenos Aires 3
Canoas 3
Guayaquil 3
Johannesburg 3
Manaus 3
Milan 3
Porto Alegre 3
San Jose 3
Santo André 3
Amsterdam 2
Ankara 2
Asunción 2
Baku 2
Barletta 2
Belo Horizonte 2
Bogotá 2
Bình Dương 2
Bắc Ninh 2
Comodoro Rivadavia 2
Council Bluffs 2
Dakar 2
Detroit 2
Duque de Caxias 2
Formosa 2
Goiânia 2
Guarulhos 2
Houston 2
Isidro Casanova 2
Kediri 2
Krasnodar 2
London 2
Maricá 2
Mumbai 2
Nairobi 2
Nha Trang 2
Phủ Lý 2
Quảng Ngãi 2
Rondonópolis 2
Rosario 2
Salt Lake City 2
Serra 2
São Gonçalo 2
Taboão da Serra 2
Tokyo 2
Tunis 2
Tây Ninh 2
Viamão 2
Vibo Valentia 2
Vĩnh Tường 2
Vũng Tàu 2
Warsaw 2
Xi'an 2
Yaroslavl 2
Acará 1
Accra 1
Agrolândia 1
Ajuricaba 1
Altos 1
Angatuba 1
Antakya 1
Anyang 1
Aparecida 1
Araguaína 1
Arapiraca 1
Totale 15.647
Nome #
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 205
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 202
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 199
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 186
Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy 178
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 178
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 178
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. 177
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 173
Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). 167
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis 164
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. 161
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 161
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 156
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern 156
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 154
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis. 154
Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines 154
Correlation between bone quality and microvascular damage in systemic sclerosis patients 151
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients. 151
Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study 150
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients 148
Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients 145
Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis 145
Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon 145
Ehlers-Danlos syndromes: state of the art on clinical practice guidelines. 144
Anti-TNF and sex hormones 142
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis 141
Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. 138
A method for counting monosodium urate crystals in synovial fluid 136
Advanced in naifold capillaroscopic analysis in systemic sclerosis 136
Progression of Organ Involvement in Systemic Sclerosis Patients with Persistent "Late" Nailfold Capillaroscopic Pattern of Microangiopathy: A Prospective Study. 135
Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. 134
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 134
CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression 131
CTLA-4 blockade in the treatment of rheumatoid arthritis: an update 131
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis. 130
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells 129
Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients 128
Osteoporosis in the elderly. 125
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment. 124
Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology. 123
BONE MINERAL DENSITY AND SEASONAL VARIATIONS IN BONE TURNOVER IN SYSTEMIC SCLEROSIS PATIENTS 122
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey 122
Vitamin D in rheumatoid arthritis. 122
Systemic lupus erythematosus: state of the art on clinical practice guidelines 122
Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. 120
Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? 119
Lower urinary tract symptoms in systemic sclerosis: a detailed investigation. 119
Vitamin D, steroid hormones, and autoimmunity. 118
[Role of videocapillaroscopy in early detection of transition from primary to secondary Raynaud's phenomenon in systemic sclerosis]. 116
RHEUMATOID VERSUS PSORIATIC ARTHRITIS: SIMILAR OR DIFFERENT BONE LOSS? 116
Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus. 116
PLASMA VITAMIN D LEVELS IN RELATION TO INSULIN RESISTANCE AND RISK OF METABOLIC SYNDROME IN RHEUMATOID ARTHRITIS PATIENTS 113
Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. 112
Capillaroscopy 2016: new perspectives in systemic sclerosis. 111
Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis. 111
VITAMIN D LEVELS AND BONE LOSS IN SYSTEMIC SCLEROSIS 108
Interaction between microbiota , diet/nutrients and immune/inflammatory response in rheumatic disease: focus on rheumatoid artrthris 106
Advanced microvascular damage associated with occurence of sarcopenia in systemic sclerosis patients: results from a retrospective cohort study. 105
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients 105
Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques. 104
New Kids on the Block in SSc-PAH: May We Futurely Nail It Additionally Down to Capillaroscopy? A Systematic Literature Review 104
VITAMIN D SERUM LEVELS CORRELATE WITH BONE MASS VALUES IN POSTMENOPAUSAL SYSTEMIC SCLEROSIS PATIENTS 103
The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis 103
Assessment of the plantar pressure and its correlation with the disease progression in patients with rheumatoid arthritis | [Valutazione della pressione plantare e correlazione con l'attività di malattia nei pazienti con artrite reumatoide] 103
Glucocorticoid management in rheumatoid arthritis: Morning or night low dose? 103
Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings 103
Comment on: Lower urinary tract symptoms in systemic sclerosis patients: a detailed investigation: reply. 101
Use of glucocorticoids and risk of infections. 100
Are there any positive effects of TNF-alpha blockers on bone metabolism? 98
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study 97
Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system’s inhibitor denosumab vs. bisphosphonates 96
Role of endothelin-1 on cell growth and fibrogenesis by primari cultures of human fibroblast: the effects of sex hormones 96
Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis. 95
Vitamin D and COVID-19: Narrative Review after 3 Years of Pandemic 94
Possible contribution of chronic inflammation in the induction of cancer in rheumatic diseases 94
Vitamin D, inflammation and immunity: review of literature and considerations on recent translational and clinical research developments 94
High-resolution Doppler ultrasound in systemic sclerosis: Analysis of digital arteries and nailfold microvasculature using 18-5 MHz and 33-9 MHz probes 92
Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. 92
Effects of anti-TNFα treatment on lipid profile in patients with active rheumatoid arthrits 92
Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis. 91
RELATIONSHIPS BETWEEN BONE LOSS AND DICKKOPF-1 (DKK-1) SERUM LEVELS IN PATIENTS WITH SYSTEMIC SCLEROSIS 91
A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions 89
Metabolic Profile and Bone Status in Post-Menopausal Women with Rheumatoid Arthritis: A Monocentric Retrospective Survey 88
Full longitudinal nailfold videocapillaroscopy analysis of microvascular changes during normal pregnancy 86
The paradox of ankylosing spondylitis: Concomitant osteoporosis and new bone formation 85
Capillaroscopic analysis of the microvascular status in mixed versus undifferentiated connective tissue disease. 84
Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease 83
The impact of transducer frequency in ultrasound evaluation of subclinical skin involvement in limited cutaneous systemic sclerosis patients. 83
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review 82
Systemic sclerosis: markers and targeted treatments 82
AB0292 BONE MINERAL DENSITY (BMD), BONE TURNOVER MARKERS (BTMS) AND EVALUATION OF MUSCULOSKELETAL SYSTEM IN PATIENTS WITH DIFFERENTIATED THYROID CANCER UNDERGOING TSH SUPPRESSIVE THERAPY 80
Plasma cortisol and cholesterol differently correlate with disease activity in a pilot group of rheumatoid arthritis patients 79
Naifold capillaroscopy in rheumatology: ready for the daily use but with care in terminology 79
The preliminary validation of laser Doppler flowmetry in systemic sclerosis in accordance with the OMERACT filter: A systematic review. 79
Nutritional Status and Bone Microarchitecture in a Cohort of Systemic Sclerosis Patients 79
CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients 79
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 78
Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease 78
Totale 12.121
Categoria #
all - tutte 59.713
article - articoli 57.363
book - libri 0
conference - conferenze 1.840
curatela - curatele 0
other - altro 275
patent - brevetti 0
selected - selezionate 0
volume - volumi 235
Totale 119.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021632 0 0 0 0 0 88 53 93 84 130 83 101
2021/20221.422 60 69 83 164 39 97 111 332 111 122 70 164
2022/20231.282 144 93 27 90 196 173 21 105 207 25 175 26
2023/20241.096 35 125 17 129 51 204 77 115 37 34 68 204
2024/20253.149 135 208 104 186 408 298 292 508 108 234 340 328
2025/20264.744 936 491 777 1.284 1.041 215 0 0 0 0 0 0
Totale 17.162